Rennova Health Inc (RNVA)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 12:38
Rennova Health Net Income (Quarterly): -1.342M for Sept. 30, 2022
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -1.342M |
| June 30, 2022 | -0.5038M |
| March 31, 2022 | -2.268M |
| December 31, 2021 | 408.24M |
| September 30, 2021 | -258.20M |
| June 30, 2021 | 9.071M |
| March 31, 2021 | -3.894M |
| December 31, 2020 | -8.478M |
| September 30, 2020 | -6.192M |
| June 30, 2020 | 2.122M |
| March 31, 2020 | -5.792M |
| December 31, 2019 | -8.902M |
| September 30, 2019 | -12.27M |
| June 30, 2019 | -13.42M |
| March 31, 2019 | -13.44M |
| December 31, 2018 | -10.17M |
| September 30, 2018 | 97.20M |
| June 30, 2018 | 45.32M |
| March 31, 2018 | -146.36M |
| December 31, 2017 | -24.03M |
| September 30, 2017 | -10.83M |
| June 30, 2017 | -10.68M |
| March 31, 2017 | -49.70M |
| December 31, 2016 | -10.50M |
| September 30, 2016 | -12.01M |
| Date | Value |
|---|---|
| June 30, 2016 | -5.862M |
| March 31, 2016 | -4.244M |
| September 30, 2015 | -0.956M |
| June 30, 2015 | -1.345M |
| March 31, 2015 | -1.776M |
| December 31, 2014 | -1.124M |
| September 30, 2014 | -1.016M |
| June 30, 2014 | -1.248M |
| March 31, 2014 | -0.951M |
| December 31, 2013 | -1.004M |
| September 30, 2013 | -0.563M |
| June 30, 2013 | -0.797M |
| March 31, 2013 | -0.813M |
| December 31, 2012 | -1.152M |
| September 30, 2012 | -1.284M |
| June 30, 2012 | -0.679M |
| March 31, 2012 | -2.227M |
| December 31, 2011 | 2.269M |
| September 30, 2011 | -0.476M |
| June 30, 2011 | -0.994M |
| March 31, 2011 | -0.704M |
| December 31, 2010 | -0.092M |
| September 30, 2010 | 0.134M |
| June 30, 2010 | -2.468M |
| March 31, 2010 | -5.394M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-258.20M
Minimum
Sep 2021
408.24M
Maximum
Dec 2021
7.012M
Average
-4.843M
Median
Net Income (Quarterly) Benchmarks
| CEL-SCI Corp | -6.710M |
| AIM ImmunoTech Inc | -12.58M |
| IGC Pharma Inc | -5.589M |
| NovaBay Pharmaceuticals Inc | -4.108M |
| Protalix BioTherapeutics Inc | -6.044M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.826M |
| Total Expenses (Quarterly) | 3.751M |
| EPS Diluted (Quarterly) | -0.0001 |